Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Stockholders' Equity (Unaudited)

v3.21.1
Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Beginning balance, value at Dec. 31, 2019 $ 6,467 $ 198,975,056 $ (192,823,958) $ 6,157,565
Beginning balance, shares at Dec. 31, 2019 64,672,893        
Stock-based compensation expense 3,137,519 3,137,519
Issuance of common stock, net of issuance costs of $2,962,790 $ 767 43,036,445 43,037,212
Issuance of common stock, net of issuance costs, shares 7,666,667        
Issuance of common stock upon exercise of stock options $ 15 15,979 15,994
Issuance of common stock upon exercise of stock options, shares 150,889        
Unrealized loss on marketable debt securities        
Net loss (29,656,800) (29,656,800)
Ending balance, value at Mar. 31, 2020 $ 7,249 245,164,999 (222,480,758) 22,691,490
Ending balance, shares at Mar. 31, 2020 72,490,449        
Beginning balance, value at Dec. 31, 2020 $ 9,885 349,358,378 (304,093,338) 45,274,925
Beginning balance, shares at Dec. 31, 2020 98,852,696        
Stock-based compensation expense 2,580,402 2,580,402
Issuance of common stock, net of issuance costs of $2,962,790 $ 2,539 58,858,262 58,860,801
Issuance of common stock, net of issuance costs, shares 25,391,710        
Issuance of common stock upon exercise of stock options $ 79 894,720 $ 894,799
Issuance of common stock upon exercise of stock options, shares 788,600       788,600
Unrealized loss on marketable debt securities (28,765) $ (28,765)
Net loss (16,065,168) (16,065,168)
Ending balance, value at Mar. 31, 2021 $ 12,503 $ 411,691,762 $ (320,158,506) $ (28,765) $ 91,516,994
Ending balance, shares at Mar. 31, 2021 125,033,006